Will more sensitive diagnostics identify tuberculosis missed by clinicians? Evaluating Xpert MTB/RIF testing in Guatemala
Authors:
Open Access
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Gaceta Sanitaria
- Vol. 34 (2) , 127-132
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized TrialPLOS Medicine, 2014
- Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trialThe Lancet, 2014
- Results from early programmatic implementation of Xpert MTB/RIF testing in nine countriesBMC Infectious Diseases, 2014
- Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic EvaluationPLOS Medicine, 2012
- Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness AnalysisPLOS Medicine, 2011
- Tuberculosis Diagnosis — Time for a Game ChangeNew England Journal of Medicine, 2010
- Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trialThe Lancet, 2007
- Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2006
- The Growing Burden of TuberculosisArchives of internal medicine (1960), 2003
- Diagnosis of Tuberculosis in Children: Increased Need for Better MethodsEmerging Infectious Diseases, 1995